AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2

Glimican-M1 Tablet PR

Prescription Icon
Prescription Required

Marketer

Alican Pharmaceutical Pvt Ltd

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Glimican-M1 Tablet PR

DiabetaComb-XR tablets are anti-diabetic medications combining two active ingredients for adult type 2 diabetes management. This dual-action formula helps regulate blood glucose. DiabetaComb-XR should be taken with meals, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may be adjusted based on blood sugar monitoring. Continuous use is crucial; abrupt cessation without medical consultation risks elevated blood sugar, potentially leading to kidney complications, vision loss, neuropathy, and limb amputation. This medication is one component of a comprehensive diabetes management plan, encompassing diet, exercise, and weight management as directed by your doctor. Lifestyle significantly impacts diabetes control. Hypoglycemia (low blood sugar) is the most prevalent side effect. Learn to recognize symptoms like sweating, dizziness, headache, and trembling, and know how to manage them. Regular meals and carrying a fast-acting glucose source (e.g., sugary snacks or juice) are essential. Alcohol consumption elevates hypoglycemia risk and should be limited. Other possible side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe liver or kidney disease. Disclose any history of heart disease to your doctor before starting treatment. Pregnant or lactating individuals should consult their physician prior to use. Regular blood sugar monitoring is necessary, and your doctor may order blood tests to check blood cell counts and liver function.

Uses of Glimican-M1 Tablet PR

Managing type 2 diabetes

Major Benefits of Glimican-M1 Tablet PR:

Follow your doctor's instructions or consult the product label for usage guidelines. Take Glimican-M1 Tablet PR with meals.

Common Side effects of Glimican-M1 Tablet PR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glimican-M1 Tablet PR:

Follow your physician's instructions or consult the product label for usage guidelines. Administer Glimican-M1 Tablet PR with meals.

How Glimican-M1 Tablet PR works:

Glimican-M1 PR tablets combine glimepiride and metformin, two medications that manage blood sugar. Glimepiride, a sulfonylurea, stimulates pancreatic insulin release to reduce blood glucose levels. Metformin, a biguanide, acts by decreasing liver glucose production, slowing intestinal glucose absorption, and enhancing insulin sensitivity.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol while taking Glimican-M1 Tablet PR is hazardous.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Glimican-M1 Tablet PR during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Breastfeeding mothers should not use Glimican-M1 Tablet PR; evidence indicates potential infant toxicity from this medication.

DrivingDrivingCAUTION

Impaired driving is possible with excessively high or low blood glucose levels. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

The use of Glimican-M1 Tablet PR requires careful consideration in individuals with impaired kidney function. Dosage modification of Glimican-M1 Tablet PR might be necessary. Physician consultation is recommended. For patients exhibiting severe kidney disease, Glimican-M1 Tablet PR is contraindicated. Routine monitoring of renal function is advised during treatment with this medication.

LiverLiverCAUTION

For individuals with liver impairment, Glimican-M1 Tablet PR requires careful administration. Dosage modification of Glimican-M1 Tablet PR may be necessary. Physician consultation is advised. A low initial dose of Glimican-M1 Tablet PR is typically prescribed for patients experiencing mild to moderate liver disease; its use is contraindicated in those with severe liver dysfunction.

What if you forget to take Glimican-M1 Tablet PR :

Should you forget a dose of Glimican-M1 Tablet PR, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glimican-M1 Tablet PR

LabelValue
Addictive None.
Type of Treatment Medication for diabetes

FAQs on Glimican-M1 Tablet PR

Maintain this medication within its original, sealed container. Store as directed on the packaging or label. Discard any leftover medication. Ensure it remains inaccessible to children, pets, and others.
Glimican-M1 Tablet PR use may result in lactic acidosis, a serious medical condition characterized by excessive blood lactic acid. Also termed Metformin-associated lactic acidosis (MALA), this rare but potentially harmful adverse effect is more likely in individuals with pre-existing kidney impairment, the elderly, or those who consume significant alcohol. Symptoms can encompass muscle aches or weakness, vertigo, fatigue, cold extremities, respiratory distress, nausea, emesis, abdominal pain, or bradycardia. Should these symptoms arise, discontinue Glimican-M1 Tablet PR and seek immediate medical attention.
Glimican-M1 Tablet PR combines glimepiride and metformin to manage type 2 diabetes mellitus (DM) in adults. This medication helps regulate blood sugar when used with a healthy diet and regular physical activity. Glimepiride stimulates insulin secretion from the pancreas, thus reducing blood glucose. Metformin reduces hepatic glucose production and enhances insulin sensitivity. This combination therapy is unsuitable for type 1 DM.
Glimican-M1 Tablet PR may cause common side effects including low blood sugar (hypoglycemia), taste changes, nausea, abdominal pain, diarrhea, and headache. Rare but serious adverse reactions such as lactic acidosis are also possible. Prolonged use might result in vitamin B12 deficiency.
Glimican-M1 Tablet PR may induce Vitamin B12 deficiency with prolonged administration due to interference with its gastric absorption. Untreated deficiency can lead to anemia, neurological complications including paresthesia in the extremities, generalized weakness, urinary dysfunction, cognitive impairment, and ataxia. Prophylactic annual supplementation of Vitamin B12 is recommended by some to mitigate these risks.
Indeed, Glimican-M1 Tablet PR can induce hypoglycemia. Characteristic symptoms of low blood sugar encompass nausea, headache, irritability, increased hunger, sweating, lightheadedness, tachycardia, and feelings of anxiety or tremor. This adverse effect is amplified by skipped or delayed meals, alcohol consumption, strenuous physical activity, or concomitant use of other antidiabetic medications. Consequently, consistent blood glucose monitoring is crucial. Maintain readily available sources of rapid-acting carbohydrates, such as glucose tablets, honey, or fruit juice.
Combining Glimican-M1 Tablet PR and alcohol is unsafe due to the risk of dangerously low blood sugar (hypoglycemia) and a heightened probability of lactic acidosis.
Glimican-M1 Tablet PR
50
MRP 61
17% off